These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28303937)

  • 1. Vitamin D inhibits lymphangiogenesis through VDR-dependent mechanisms.
    Yazdani S; Poosti F; Toro L; Wedel J; Mencke R; Mirković K; de Borst MH; Alexander JS; Navis G; van Goor H; van den Born J; Hillebrands JL
    Sci Rep; 2017 Mar; 7():44403. PubMed ID: 28303937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.
    Sanchez-Niño MD; Bozic M; Córdoba-Lanús E; Valcheva P; Gracia O; Ibarz M; Fernandez E; Navarro-Gonzalez JF; Ortiz A; Valdivielso JM
    Am J Physiol Renal Physiol; 2012 Mar; 302(6):F647-57. PubMed ID: 22169009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
    Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
    BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats.
    Yazdani S; Hijmans RS; Poosti F; Dam W; Navis G; van Goor H; van den Born J
    Dis Model Mech; 2015 Aug; 8(8):919-30. PubMed ID: 26035383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.
    Mu H; Calderone TL; Davies MA; Prieto VG; Wang H; Mills GB; Bar-Eli M; Gershenwald JE
    Am J Pathol; 2012 May; 180(5):2170-81. PubMed ID: 22465753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
    Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
    Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VDR Activation Reduces Proteinuria and High-Glucose-Induced Injury of Kidneys and Podocytes by Regulating Wnt Signaling Pathway.
    Guo J; Lu C; Zhang F; Yu H; Zhou M; He M; Wang C; Zhao Z; Liu Z
    Cell Physiol Biochem; 2017; 43(1):39-51. PubMed ID: 28848172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor activators upregulate and rescue podocalyxin expression in high glucose-treated human podocytes.
    Verouti SN; Tsilibary EC; Fragopoulou E; Iatrou C; Demopoulos CA; Charonis AS; Charonis SA; Drossopoulou GI
    Nephron Exp Nephrol; 2012; 122(1-2):36-50. PubMed ID: 23548800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells.
    Zhuo W; Luo C; Wang X; Song X; Fu Y; Luo Y
    J Pathol; 2010 Nov; 222(3):249-60. PubMed ID: 20814900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
    Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
    J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assays using primary embryonic mouse lymphatic endothelial cells uncover key roles for FGFR1 signalling in lymphangiogenesis.
    Kazenwadel J; Secker GA; Betterman KL; Harvey NL
    PLoS One; 2012; 7(7):e40497. PubMed ID: 22792354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D receptor knockdown attenuates the antiproliferative, pro‑apoptotic and anti‑invasive effect of vitamin D by activating the Wnt/β‑catenin signaling pathway in papillary thyroid cancer.
    Pang R; Xu Y; Hu X; Liu B; Yu J
    Mol Med Rep; 2020 Nov; 22(5):4135-4142. PubMed ID: 33000217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucoxanthin inhibits tumour-related lymphangiogenesis and growth of breast cancer.
    Wang J; Ma Y; Yang J; Jin L; Gao Z; Xue L; Hou L; Sui L; Liu J; Zou X
    J Cell Mol Med; 2019 Mar; 23(3):2219-2229. PubMed ID: 30648805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vitamin D analogs on the expression of plasminogen activator inhibitor-1 in human vascular cells.
    Wu-Wong JR; Nakane M; Ma J
    Thromb Res; 2006; 118(6):709-14. PubMed ID: 16371233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells.
    Prangsaengtong O; Jantaree P; Lirdprapamongkol K; Ngiwsara L; Svasti J; Koizumi K
    Vasc Med; 2018 Jun; 23(3):201-211. PubMed ID: 29629844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFβ signaling is required for sprouting lymphangiogenesis during lymphatic network development in the skin.
    James JM; Nalbandian A; Mukouyama YS
    Development; 2013 Sep; 140(18):3903-14. PubMed ID: 23946447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.
    Lin T; Gong L
    Drug Des Devel Ther; 2017; 11():1147-1158. PubMed ID: 28435226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet interaction with lymphatics aggravates intestinal inflammation by suppressing lymphangiogenesis.
    Sato H; Higashiyama M; Hozumi H; Sato S; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Narimatsu K; Yoshikawa K; Kurihara C; Okada Y; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Hokari R
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G276-85. PubMed ID: 27313177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of cyclic phosphatidic acid-induced lymphangiogenic actions in vitro.
    Okuyama K; Mizuno K; Nittami K; Sakaue H; Sato T
    Microvasc Res; 2022 Jan; 139():104273. PubMed ID: 34699844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.